Physician profile
Beatriz E Juncadella
NPI 1265400998
$1,109.75
in general payments reported to CMS, 2019-2025
19 companies · $151 in 2025
The $151 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $236 · 2020: $123 · 2021: $166 · 2022: $146 · 2023: $111 · 2024: $178 · 2025: $151.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $201.85 | 2019-2025 | |
| Corium, LLC | $148.42 | 2021-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $125.14 | 2019-2024 | Jornay Pm |
| Cranial Technologies, INC | $111.45 | 2020-2025 | Doc Band |
| Glaxosmithkline, LLC. | $94.02 | 2019-2025 | Bexsero, Penmenvy |
| Takeda Pharmaceuticals U.S.A., INC. | $82.23 | 2019-2021 | |
| Supernus Pharmaceuticals, INC. | $60.41 | 2022-2023 | Qelbree |
| Merck Sharp & Dohme LLC | $60.14 | 2020-2025 | Rotateq, Vaxneuvance, Gardasil 9 |
| Tris Pharma INC | $43.78 | 2022-2024 | Onyda Xr |
| Collegium Pharmaceutical, INC. | $38.49 | 2025 | Jornay Pm |
| Aytu Biopharma, INC. | $25.88 | 2020-2023 | Karbinal |
| Vertical Pharmaceuticals, LLC | $20.88 | 2024 | Relexxii |
| Sobi, INC | $18.23 | 2019 | |
| Amneal Pharmaceuticals LLC | $14.99 | 2019 | |
| Biomarin Pharmaceutical INC. | $13.60 | 2025 | Voxzogo 1.2mg |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $13.14 | 2019 | |
| Shire North American Group INC | $12.71 | 2019 | |
| Neos Therapeutics, LP | $12.26 | 2022 | |
| Genentech USA, INC. | $12.13 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Beatriz Juncadella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.